BMCM
NBSE

Bryn Mawr Capital Management’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Bryn Mawr Capital Management’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-36
Closed -$3K – 92
2018
Q3 		$3K Hold
36
– – ﹤0.01% 88
2018
Q2 		$3K Hold
36
– – ﹤0.01% 93
2018
Q1 		$3K Buy
+36
New +$3K ﹤0.01% 85